IPO listing: Bansal Wire shares debut 39% higher; Emcure Pharma at 31% premium
Post listing, Emcure Pharma shares gained as much as 37.3% to ₹1,384, while Bansal Wire shares jumped 44% to hit a high of ₹368.7 on the BSE.
Post listing, Emcure Pharma shares gained as much as 37.3% to ₹1,384, while Bansal Wire shares jumped 44% to hit a high of ₹368.7 on the BSE.
Ahead of opening of their IPOs, Emcure Pharma raised ₹582.6 cr via anchor book, while Bansal Wire garnered ₹223.5 cr through anchor investors.
Emcure Pharmaceuticals looks to raise ₹1,952 crore via IPO, while Bansal Wire Industries aims to garner ₹745 crore.